A Real Life Experience with the Comsos Regimen in Genotype 1 Chronic Hepatitis C Treatment: Including Patients with East Asian Ancestry and Decompensated Cirrhosis

BACKGROUND/AIMS: The COMSOS phase 2 trial showed high cure rates and a favorable side effect profile of a 12-week regimen of Sofosbuvir (SOF) and Simeprevir (SIM) in patients with a genotype 1 Hepatitis C infection. However, given the small number of patients in the COSMOS trial, there is uncertaint...

全面介紹

Na minha lista:
書目詳細資料
發表在:Hawaii J Med Public Health
Main Authors: Roytman, Marina, Ramkissoon, Resham, Hong, Leena, Trujillo, Ruby, Huddleston, Leslie, Poerzgen, Peter, Seto, Todd, Tsai, Naoky
格式: Artigo
語言:Inglês
出版: University Clinical, Education & Research Associate (UCERA) 2015
主題:
Abstracts
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4582373/
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍